TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32817593

Group type: EXPERIMENTAL
Intervention: H3.3K27M-targeted peptide vaccine administered with poly-ICLC every 3 weeks for 8 cycles, then every 6 weeks.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: H3.3K27M-targeted peptide vaccine with observed immunological responses.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: H3.3K27M-targeted peptide vaccine in patients with below-median baseline levels of myeloid-derived suppressor cells.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Immediate pretreatment dexamethasone administration.
Number of subjects: 29
Study: 32817749

Group type: EXPERIMENTAL
Intervention: Very Low Carbohydrate Diet (VLCD)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 34
Study: 32817798

Group type: EXPERIMENTAL
Intervention: Accelerometer values for inactivity (<1.5 METs)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Accelerometer values for MVPA (≥3.0 METs)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Measured METs during standing and walking activities
Number of subjects: 22
Study: 32817978

Group type: EXPERIMENTAL
Intervention: Convalescent plasma transfusion within 3 days of COVID-19 diagnosis
Number of subjects: 35322

Group type: EXPERIMENTAL
Intervention: Convalescent plasma transfusion 4 or more days after COVID-19 diagnosis
Number of subjects: 35322

Group type: EXPERIMENTAL
Intervention: High IgG plasma (>18.45 S/Co)
Number of subjects: 35322

Group type: EXPERIMENTAL
Intervention: Medium IgG plasma (4.62 to 18.45 S/Co)
Number of subjects: 35322

Group type: EXPERIMENTAL
Intervention: Low IgG plasma (<4.62 S/Co)
Number of subjects: 35322

Group type: EXPERIMENTAL
Intervention: High antibody level plasma units
Number of subjects: 35322
Study: 32818157

Group type: EXPERIMENTAL
Intervention: 5-day challenge with penicillin
Number of subjects: 305

Group type: COMPARATOR
Intervention: Single full dose of penicillin
Number of subjects: 305
Study: 32818236

Group type: EXPERIMENTAL
Intervention: Ter allele of Rs752074397 in DAO
Number of subjects: 373
Study: 32818460

Group type: EXPERIMENTAL
Intervention: Preoperative oral antibiotics
Number of subjects: 0
Study: 32818466

Group type: EXPERIMENTAL
Intervention: Dabrafenib plus trametinib
Number of subjects: 43
Study: 32818917

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (ESK) plus oral antidepressant (OAD)
Number of subjects: 23
Study: 32819275

Group type: EXPERIMENTAL
Intervention: Increased fasting plasma glucose (FPG)
Number of subjects: 7762

Group type: COMPARATOR
Intervention: Normal fasting plasma glucose (FPG)
Number of subjects: 7762
Study: 32819310

Group type: EXPERIMENTAL
Intervention: Excessive gestational weight gain
Number of subjects: 124

Group type: COMPARATOR
Intervention: Adequate gestational weight gain
Number of subjects: 124

Group type: COMPARATOR
Intervention: Insufficient gestational weight gain
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Gestational weight gain categories
Number of subjects: 124
Study: 32819311

Group type: EXPERIMENTAL
Intervention: Symptom-based scoring system (paper-based questionnaire) during and up to 24 weeks following radiotherapy.
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Standard diagnostic procedures if radiation pneumonitis is suspected.
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Mobile application functionality testing in 10 patients in addition to the paper-based questionnaire.
Number of subjects: 98
Study: 32819400

Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Tidal volume of 6.8 mL/kg
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) of 8 cmH2O
Number of subjects: 527

Group type: COMPARATOR
Intervention: Incidence of ARDS
Number of subjects: 527

Group type: COMPARATOR
Intervention: Mortality and withdrawal of life-sustaining care
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Lung protective strategy compliance
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Adjunct treatment
Number of subjects: 527
Study: 32819449

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 64
Study: 32819469

Group type: EXPERIMENTAL
Intervention: Unrecognized myocardial infarction (UMI)
Number of subjects: 2349

Group type: COMPARATOR
Intervention: Recognized myocardial infarction (RMI)
Number of subjects: 2349
Study: 32819481

Group type: EXPERIMENTAL
Intervention: Post-PCI FFR >0.80
Number of subjects: 588

Group type: COMPARATOR
Intervention: Post-PCI FFR ≤0.80
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Post-PCI Pd/Pa >0.92
Number of subjects: 588

Group type: COMPARATOR
Intervention: Post-PCI Pd/Pa ≤0.92
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Post-PCI Pd/Pa ≤0.92 and FFR ≤0.80
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Post-PCI Pd/Pa ≤0.92 but FFR >0.80
Number of subjects: 588
Study: 32819531

Group type: EXPERIMENTAL
Intervention: THERMOCOOL SMARTTOUCH SF Catheter
Number of subjects: 381
Study: 32819881

Group type: EXPERIMENTAL
Intervention: R2V2 (Vorinostat plus Bortezomib, Lenalidomide, and Dexamethasone)
Number of subjects: 30
Study: 32819883

Group type: EXPERIMENTAL
Intervention: ASA24 recalls
Number of subjects: 1077

Group type: COMPARATOR
Intervention: 4DFRs
Number of subjects: 1077

Group type: COMPARATOR
Intervention: FFQs
Number of subjects: 1077
Study: 32819953

Group type: EXPERIMENTAL
Intervention: Involvement of fathers in care-seeking processes for sick children
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Financial responsibility for child healthcare
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Awareness of health services
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Changing perceptions of paternal responsibilities
Number of subjects: 24
Study: 32819957

Group type: EXPERIMENTAL
Intervention: COpenhagen ROsacea COhort (COROCO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: COpenhagen MIgraine COhort (COMICO)
Number of subjects: 0
Study: 32819972

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg every 3 weeks for four doses combined with radiotherapy (9, 15, 18, and 24 Gy) at week 4.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Radiotherapy combined with ipilimumab.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Radiotherapy (9 Gy) combined with ipilimumab.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg every 12 weeks for maintenance after week 24 for patients with clinical benefit.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Not applicable (no control group mentioned).
Number of subjects: 19
Study: 32819975

Group type: EXPERIMENTAL
Intervention: Focused ultrasound (FUS) combined with gemcitabine (GEM); specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Focused ultrasound (FUS) monotherapy; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FUS+GEM with either neoadjuvant or adjuvant treatment with anti-PD-1; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 32819978

Group type: EXPERIMENTAL
Intervention: Chronic complications assessment
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Insulin resistance assessment
Number of subjects: 806
Study: 32819989

Group type: COMPARATOR
Intervention: Gingival inflammation (BOP ≥30%)
Number of subjects: 1394

Group type: COMPARATOR
Intervention: Gingival inflammation (BOP ≥30%) in first trimester
Number of subjects: 1394

Group type: COMPARATOR
Intervention: Gingival inflammation (BOP ≥30%) later in pregnancy
Number of subjects: 1394

Group type: COMPARATOR
Intervention: Mild periodontitis
Number of subjects: 1394

Group type: COMPARATOR
Intervention: Overall preterm birth incidence
Number of subjects: 1394
Study: 32819996

Group type: EXPERIMENTAL
Intervention: Minimally invasive radical hysterectomy (MIRH)
Number of subjects: 2800

Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy (ARH)
Number of subjects: 2800
Study: 32820223

Group type: EXPERIMENTAL
Intervention: Metalloproteinase (MMP)-9 expression in AT
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tissue inhibitor of MMP (TIMP)-1 expression in AT
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Plasminogen activator inhibitor (PAI)-1 expression in AT
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity measured by glucose clamp technique
Number of subjects: 103
Study: 32820369

Group type: EXPERIMENTAL
Intervention: Pretargeted immuno-PET using anti-CEA recombinant bispecific monoclonal antibody (BsMAb) TF2 and gallium-68-labelled IMP-288 peptide
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pretargeted immuno-PET
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: BsMAb and peptide injections
Number of subjects: 11
Study: 32820452

Group type: EXPERIMENTAL
Intervention: β-glucan, 200 mg/day for 8 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Logistic model for PQD risk score
Number of subjects: 37
Study: 32820453

Group type: EXPERIMENTAL
Intervention: Integrated Chinese and Western medicine (ICM) group receiving CM herbal treatment combined with Western medicine (WM) anti-tumor therapy
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) group receiving only CM herbal treatment
Number of subjects: 384

Group type: COMPARATOR
Intervention: WM group receiving only WM anti-tumor therapy
Number of subjects: 384
Study: 32820536

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 6894

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 6894
Study: 32820618

Group type: EXPERIMENTAL
Intervention: Acetylcarnitine concentrations in type 2 diabetes patients
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Intramyocellular lipid concentrations in type 2 diabetes patients
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intramyocellular lipids
Number of subjects: 35

Group type: COMPARATOR
Intervention: Acetylcarnitine
Number of subjects: 35
Study: 32821007

Group type: EXPERIMENTAL
Intervention: Initial serum concentrations of GFAP
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Initial serum concentrations of UCH-L1
Number of subjects: 145
Study: 32821164

Group type: EXPERIMENTAL
Intervention: Apatinib monotherapy
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Apatinib combination therapy
Number of subjects: 737

Group type: COMPARATOR
Intervention: Apatinib (both monotherapy and combination)
Number of subjects: 737
Study: 32821287

Group type: EXPERIMENTAL
Intervention: Clarithromycin triple therapy with add-on NAC
Number of subjects: 680

Group type: COMPARATOR
Intervention: Clarithromycin triple therapy alone
Number of subjects: 680
Study: 32821419

Group type: EXPERIMENTAL
Intervention: Vaginal dinoprostone (Propess)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Cervical ripening balloon catheter (CRB)
Number of subjects: 274
Study: 32821422

Group type: EXPERIMENTAL
Intervention: Self-administration of medication (SAM) during hospitalization
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nurse-led dispensing (Control)
Number of subjects: 60
Study: 32821712

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (4 g/day) plus statin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Statin only
Number of subjects: 56
Study: 32821737

Group type: EXPERIMENTAL
Intervention: New generic rosuvastatin 10 mg daily for 8 weeks
Number of subjects: 126

Group type: COMPARATOR
Intervention: Proprietary rosuvastatin 10 mg daily for 8 weeks
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 126
Study: 32822476

Group type: EXPERIMENTAL
Intervention: Coronary Computed Tomographic Angiography (CCTA)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Myocardial Perfusion Imaging
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Invasive FFR measurement
Number of subjects: 612
Study: 32822482

Group type: EXPERIMENTAL
Intervention: Ixazomib, dexamethasone, and rituximab (IDR)
Number of subjects: 26
Study: 32822634

Group type: EXPERIMENTAL
Intervention: SCA1 mutation carriers
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: SCA2 mutation carriers
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: SCA3 mutation carriers
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: SCA6 mutation carriers
Number of subjects: 252

Group type: COMPARATOR
Intervention: SCA1 non-carriers
Number of subjects: 252

Group type: COMPARATOR
Intervention: SCA2 non-carriers
Number of subjects: 252
Study: 32822675

Group type: EXPERIMENTAL
Intervention: Robotic bronchoscopy with radial probe endobronchial ultrasound (R-EBUS) imaging
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Robotic bronchoscopy
Number of subjects: 54
Study: 32823563

Group type: EXPERIMENTAL
Intervention: CDN MK-1454
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CDN ADU-S100
Number of subjects: 0
Study: 32823781

Group type: EXPERIMENTAL
Intervention: Delirium screening tools used in patients with varying sedation levels and ventilation status.
Number of subjects: 0
Study: 32824065

Group type: EXPERIMENTAL
Intervention: Higher protein intake (mean 82.2 ± 21.3 g/d)
Number of subjects: 730

Group type: COMPARATOR
Intervention: Moderate fatigue (CIS score 20-34)
Number of subjects: 730

Group type: COMPARATOR
Intervention: Severe fatigue (CIS score ≥ 35)
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL) assessed with RAND-36
Number of subjects: 730
Study: 32824392

Group type: EXPERIMENTAL
Intervention: Primary tumor resection (PTR) followed by chemotherapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Upfront chemotherapy alone
Number of subjects: 48
Study: 32825827

Group type: EXPERIMENTAL
Intervention: Sternal reconstruction using titanium plates
Number of subjects: 5
Study: 32826283

Group type: EXPERIMENTAL
Intervention: ASQ (Ask Suicide-Screening Questions)
Number of subjects: 600
Study: 32826289

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation attendees
Number of subjects: 4570

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation attendees who were physically active ≥150 min/week
Number of subjects: 4570

Group type: COMPARATOR
Intervention: Cardiac rehabilitation
Number of subjects: 4570

Group type: COMPARATOR
Intervention: Self-reported physical activity of ≥150 min/week
Number of subjects: 4570
Study: 32826449

Group type: EXPERIMENTAL
Intervention: Stable angina
Number of subjects: 49

Group type: COMPARATOR
Intervention: NSTEMI
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 49
Study: 32827042

Group type: EXPERIMENTAL
Intervention: Endurance training (3 × 1 hour/week at 80% VO2 peak for 8 weeks)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 25
Study: 32827160

Group type: EXPERIMENTAL
Intervention: Dalteparin 150 IU/kg every 12 hours for ages 1 month to <2 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dalteparin 125 IU/kg every 12 hours for ages ≥2 to <8 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dalteparin 100 IU/kg every 12 hours for ages ≥8 to <19 years
Number of subjects: 0
Study: 32827219

Group type: EXPERIMENTAL
Intervention: Reducing saturated fat intake
Number of subjects: 56675
Study: 32827353

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) combined with novel molecular-targeted agents (MTAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiation therapy (RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Novel molecular-targeted agents (MTAs)
Number of subjects: 0
Study: 32827595

Group type: EXPERIMENTAL
Intervention: Diabetes clinics (T2DM)
Number of subjects: 3028

Group type: COMPARATOR
Intervention: Primary care (T2DM)
Number of subjects: 3028

Group type: COMPARATOR
Intervention: General population (without diabetes)
Number of subjects: 3028

Group type: EXPERIMENTAL
Intervention: Diabetes clinics (T2DM with prior CV events)
Number of subjects: 3028

Group type: COMPARATOR
Intervention: Primary care (T2DM with prior CV events)
Number of subjects: 3028

Group type: COMPARATOR
Intervention: General population (without diabetes with prior CV events)
Number of subjects: 3028
Study: 32827724

Group type: EXPERIMENTAL
Intervention: Gluten-Free Diet (GFD) for 4 weeks
Number of subjects: 50
Study: 32828322

Group type: EXPERIMENTAL
Intervention: Personalized breast cancer risk report
Number of subjects: 337
Study: 32828495

Group type: EXPERIMENTAL
Intervention: Robotics-assisted laparoscopy
Number of subjects: 8
Study: 32828741

Group type: EXPERIMENTAL
Intervention: Methylene blue-vitamin C-N-acetyl Cysteine (MCN)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 25
Study: 32828763

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1255
Study: 32828839

Group type: EXPERIMENTAL
Intervention: MLC tracking
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Gating
Number of subjects: 44

Group type: COMPARATOR
Intervention: No motion adaptation strategy
Number of subjects: 44
Study: 32829467

Group type: EXPERIMENTAL
Intervention: Antiviral and immunomodulator treatment
Number of subjects: 1
Study: 32829481

Group type: EXPERIMENTAL
Intervention: Alternative modes of exercise therapy (cycling, lower-extremity resistance training, upper-arm ergometry, Nordic walking, combinations of exercise modes)
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Alternative modes of exercise therapy
Number of subjects: 527
Study: 32830125

Group type: EXPERIMENTAL
Intervention: Anterior curvature (A)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Posterior curvature (B)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Thinnest pachymetry (C)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Best distance visual acuity (D)
Number of subjects: 1000
Study: 32830603

Group type: EXPERIMENTAL
Intervention: Force-feedback condition
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Posture-feedback condition
Number of subjects: 36
Study: 32830626

Group type: EXPERIMENTAL
Intervention: Nutrition education classes offered in conjunction with a cost-offset community-supported agriculture (CSA) programme
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Nutrition education classes
Number of subjects: 96
Study: 32830851

Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD)
Number of subjects: 20
Study: 32831103

Group type: EXPERIMENTAL
Intervention: Activity Preference Assessment (APA)
Number of subjects: 60
Study: 32831121

Group type: EXPERIMENTAL
Intervention: Circulating proteins in HFpEF patients
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Sex differences in HFpEF
Number of subjects: 392
Study: 32831183

Group type: EXPERIMENTAL
Intervention: Cash with LNS, Cash with SBCC, Cash with SBCC and LNS
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Cash only
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Routine standard of care
Number of subjects: 2000
Study: 32832143

Group type: EXPERIMENTAL
Intervention: Qualitative clinical method
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Quantitative photographic method
Number of subjects: 42
Study: 32832208

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training for PDS implant insertion and refill-exchange procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDS 100 mg/mL with fixed 24-week refills
Number of subjects: 0
Study: 32832558

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 0
Study: 32832914

Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiography in prone position
Number of subjects: 27
Study: 32833107

Group type: EXPERIMENTAL
Intervention: Peritoneal fluid instillation (FI)
Number of subjects: 387

Group type: COMPARATOR
Intervention: No peritoneal fluid instillation (NFI)
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) with FI
Number of subjects: 387

Group type: COMPARATOR
Intervention: Non-negative pressure wound therapy (non-NPWT) with NFI
Number of subjects: 387
Study: 32833193

Group type: EXPERIMENTAL
Intervention: Severe depressive symptoms
Number of subjects: 455
Study: 32833482

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Affect labeling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Psychoeducational control
Number of subjects: 120
Study: 32833717

Group type: EXPERIMENTAL
Intervention: Preoperative medications
Number of subjects: 2375

Group type: EXPERIMENTAL
Intervention: Home medications for comorbidities
Number of subjects: 2375

Group type: EXPERIMENTAL
Intervention: Intraoperative acetaminophen
Number of subjects: 2375

Group type: EXPERIMENTAL
Intervention: Otolaryngologic preoperative comorbidity
Number of subjects: 2375

Group type: EXPERIMENTAL
Intervention: Total comorbidities
Number of subjects: 2375

Group type: EXPERIMENTAL
Intervention: Recent upper respiratory infection
Number of subjects: 2375

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia induction
Number of subjects: 2375
Study: 32834829

Group type: EXPERIMENTAL
Intervention: Peanut challenge (open-labelled)
Number of subjects: 36
Study: 32835353

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0
Study: 32835719

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obesity with Lynch syndrome
Number of subjects: 0

Group type: COMPARATOR
Intervention: Women without obesity
Number of subjects: 0
Study: 32835823

Group type: EXPERIMENTAL
Intervention: Curvilinear features of visual stimuli
Number of subjects: 0
Study: 32835865

Group type: EXPERIMENTAL
Intervention: Cerene Cryotherapy Device
Number of subjects: 242
Study: 32836087

Group type: COMPARATOR
Intervention: Electrophysiological connectivity in MDD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low frequency power fluctuations (delta and theta)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hub areas (left hippocampus, left anterior insula, bilateral dorsolateral prefrontal cortex)
Number of subjects: 0
Study: 32838109

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard-of-care)
Number of subjects: 0
Study: 32838323

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 764

Group type: COMPARATOR
Intervention: No Tocilizumab (Control)
Number of subjects: 764